慢性间歇性乙醇在小鼠中通过独立于内分泌素 (endocannabinoid) 的机制产生 nociception
C Miliano1, Y Dong1, M Proffit1
1School of Neuroscience, Virginia Polytechnic and State University, 970 Washington Street SW, Blacksburg, VA 24061.
Neuropharmacology
|May 13, 2025
概括
准脂质信号通路并没有缓解小鼠的酒精戒断疼痛. 目前FDA批准的药物和脂质酶抑制剂未能治疗与饮酒相关的疼痛过敏症.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 生物化学 生物化学
背景情况:
- 酒精使用障碍 (AUD) 构成了全球重大的健康和经济挑战.
- 疼痛,尤其是酒精戒断期间的高卡提菲亚,是AUD患者常见但未得到充分治疗的症状.
- 目前没有FDA批准的药物用于治疗AUD中与酒精戒断相关的疼痛.
研究的目的:
- 调查针对酒精戒断引起的疼痛过敏的生物活性脂质信号通路的治疗潜力.
- 评估FDA批准的纳尔特雷和FAAH,MAGL和15-LOX抑制剂在治疗酒精戒断期间疼痛的疗效.
主要方法:
- 在雄性和雌性C57BL/6J小鼠中使用慢性间歇性乙醇 (CIE) 蒸汽暴露模型来诱导酒精依赖.
- 在酒精戒断期间评估了触觉和热过敏症.
- 采用交叉设计来测试纳尔德,FAAH,MAGL和15-LOX抑制剂的疼痛逆转.
- 在戒断期间测量了男性和女性的血内分类素水平.
主要成果:
- 在戒断期间,CIE暴露诱导了强烈的触觉和热性过敏症,独立于血中酒精含量.
- 测试中的任何一种药物 (纳尔特雷,FAAH,MAGL,15-LOX抑制剂) 都没有显著地逆转CIE诱导的触觉性全力学.
- 这些化合物在其他慢性疼痛模型中显示出有效性,但在这种酒精戒断模型中没有.
- 观察到基线内分类素基调的性别差异,而CIE仅在女性中影响了内分类素水平.
结论:
- 针对FAAH,MAGL和15-LOX,或使用纳尔特雷,对于治疗已确定的酒精戒断引起的疼痛过敏症是无效的.
- 这些发现凸显了进一步研究AUD相关疼痛背后的机制的需要.
- 需要新的治疗策略来有效地管理AUD患者在戒断期间的疼痛.
更多相关视频
07:23Assessment of Morphine-induced Hyperalgesia and Analgesic Tolerance in Mice Using Thermal and Mechanical Nociceptive Modalities
Published on: July 29, 2014
33.2K
05:38Author Spotlight: Utilizing Infraorbital Nerve Ligation in Mice for Investigating Trigeminal Neuropathic Pain and Treatment Strategies
Published on: March 8, 2024
1.4K
相关概念视频
CNS Depressants: Alcohol and Nicotine
166
Ethanol, a clear colorless alcohol, has been consumed by humans for millennia, but its effects on the body are far from benign. At lower doses, it induces decreased inhibitions and loquaciousness, leading to its social appeal. However, it can cause severe consequences at higher doses, such as coma and respiratory depression, due to its zero-order elimination kinetics. Chronic ethanol abuse wreaks havoc on multiple organ systems, particularly the CNS and the liver. Abrupt cessation of ethanol...
166
Analgesia and Pain Management
415
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
415
